Study of DNA repair mechanisms that affect chemosensitivity of breast cancer
Study of DNA repair mechanisms that affect chemosensitivity of breast cancer
批准号:
18591446
负责人:
OHTA Tomohiko
金额:
$2.55万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007
中文摘要
为了阐明乳腺癌化疗敏感性的DNA损伤修复机制,我研究了乳腺和卵巢肿瘤抑制因子BRCA 1对DNA损伤反应的底物泛素化作用。我以前鉴定了几种底物,包括核磷蛋白(NPM 1/B23)和RNA聚合酶的常见亚基RPB 8。本人在2006年主要研究了RPB 8,发现1)内源性RPB 8与BARD 1相互作用,2)RPB 8在体外被纯化的BRCA 1-BARD 1多聚泛素化,3)在RPB 8泛素化过程中形成Lys 6连接的泛素聚合物,4)通过siRNA敲低BRCA 1抑制UV照射后的体内RPB 8泛素化,5)通过BRCA 1的siRNA敲低使内源性RPB 8蛋白在体内不稳定。6)稳定表达RPB 8的泛素抗性形式的HeLa细胞系表现出UV超敏性,伴随着上调的半胱天冬酶活性和p53在Ser 15处的磷酸化。2006年,我主要研究了NPM 1。建立了稳定表达不能被BRCA 1泛素化的NPM 1突变体的细胞系,并研究了其生物学意义。然而,我最终得出结论,细胞不表达由泛素化缺陷引起的表型。然后,仅使用纯化的重组蛋白重建体外NPM 1泛素化系统,以研究NPM 1泛素化对NPM 1的组蛋白伴侣活性的影响。进一步构建了NPM 1、BRCA 1-BARD 1异源二聚体、Ube 2 w、Ubc 13和Mms 2等重组蛋白,并建立了Lys 63连接的NPM 1多聚泛素化系统来研究DNA损伤反应。
英文摘要
I have investigated the role of substrate ubiquitination by the breast and ovarian tumor suppressor BRCA1 on DNA damage response to elucidate the DNA damage repair mechanisms underlying chemosensitivity of breast cancer I previously identified several substrates including nucleophosmin (NPM1/B23) and RPB8, a common subunit of RNA polymerases. I have mainly investigated RPB8 in 2006 and found that 1) endogenous RPB8 interacts with BARD1, 2) RPB8 polyubiquitination by purified BRCAl-BARD1 in vitro, 3) Lys6-linked ubiquitin polymer formation in the RPB8 ubiquitination, 4) inhibition of in vivo RPB8 ubiquitination after UV irradiation by siRNA knockdown of BRCA1, 5) destabilization of endogenous RPB8 protein in vivo by siRNA knockdown of BRCA1, 6) HeLa cell lines stably expressing a ubiquitin-resistant form of RPB8 exhibited UV hypersensitivity accompanied by up-regulated caspase activity and p53 phosphorylation at Ser15. In 2006 I have mainly investigated NPM1. I established a cell lines stably expressing NPM1 mutant that is incapable of being ubiquitinated by BRCA1 and investigated its biological significance. However I finally concluded that the cells did not express the phenotype caused by the deficiency of the ubiquitination. I then reconstituted an in vitro NPM1 ubiquitination system using only purified recombinant proteins to investigate the effect of NPM1 ubiquitination on histone chaperone activity of NPM1. I further created recombinant proteins including NPM1, BRCA1-BARD1 heterodimer, Ube2w, Ubc13, and Mms2 and established Lys63-linked NPM1 polyubiquitination system to study DNA damage response.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Predictive markers in breast cancer treatment-focusing on a recent topicbasal-like breast cancer
乳腺癌治疗的预测标志物——关注近期的基底样乳腺癌
DOI:
--
发表时间:
2007
期刊:
Nippon Rinsho.(Suppl 6) 65
影响因子:
--
作者:
[Koike A, Ohta T.]
通讯作者:
Ohta T.
乳癌および卵巣癌抑制遺伝子BRCA1
乳腺癌和卵巢癌抑制基因BRCA1
DOI:
--
发表时间:
2006
期刊:
PNE:蛋白核酸酵素 51
影响因子:
--
作者:
[Hashino Isamu, Matsushita Kazuyuki, et. al. (other 7 authors), 太田 智彦]
通讯作者:
太田 智彦
治療効果予測マーカー-最近のトピック,basal-like乳癌に焦点を当てて-
治疗效果预测标记 - 近期主题,重点关注基底样乳腺癌 -
DOI:
--
发表时间:
2007
期刊:
日本臨床 65(Sup.)
影响因子:
--
作者:
[小池彩華, et. al.]
通讯作者:
et. al.
乳癌および卵巣癌抑制におけるBRCA1酵素活性の役割
BRCA1 酶活性在抑制乳腺癌和卵巢癌中的作用
DOI:
--
发表时间:
2006
期刊:
影响因子:
--
作者:
[太田 智彦, Ohta T., 太田 智彦, Ohta T., 太田 智彦]
通讯作者:
太田 智彦
Involvement of kinesin famiy member 2C/mitotic centromere-associated kinesin overexpression in mammary carcinogenesis.
驱动蛋白家族成员 2C/有丝分裂着丝粒相关驱动蛋白过度表达参与乳腺癌发生。
DOI:
--
发表时间:
2007
期刊:
Cancer Sci. 99(1)
影响因子:
--
作者:
[Arata Shimo, et. al.]
通讯作者:
et. al.
共 30 条
A study of mechanism underlying carcinogenesis promoted by estrogen receptor in BRCA1 deficient cells
-
批准号:16K15712
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.16万
-
财政年份:2016
-
负责人:OHTA Tomohiko
-
依托单位:
Unravelling the mechanism of ovarian carcinogenesis caused by BRCA1 depletion and estrogen action
-
批准号:26670730
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.33万
-
财政年份:2014
-
负责人:OHTA Tomohiko
-
依托单位:
Functional analysis of BRCA1 as the molecular basis of breast cancer therapy
-
批准号:26290042
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.65万
-
财政年份:2014
-
负责人:OHTA Tomohiko
-
依托单位:
Research on the breast cancer chemotherapy targeting synthetic lethality caused by the factors in the DNA damage repair pathways.
-
批准号:23300358
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$14.06万
-
财政年份:2011
-
负责人:OHTA Tomohiko
-
依托单位:
Analyses of DNA damage response to neoadjuvant chemotherapy in basal-like breast cancer
-
批准号:20591557
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2008
-
负责人:OHTA Tomohiko
-
依托单位:
Mechanisms that regulate chromosomal stability through the ubiquitin lipase activity of BRCA1
-
批准号:16591280
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:2004
-
负责人:OHTA Tomohiko
-
依托单位:
国内基金
海外基金
登录
查看更多内容
靶向NMD调控BARD1异常剪接体衰变在MDS中的机制研究
-
批准号:82300163
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:王路
-
依托单位:
BARD1胚系突变在乳腺癌DNA损伤应答中的作用及潜在临床意义
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:姚璐
-
依托单位:
BARD1识别损伤的染色质并启动同源重组修复的机制研究
-
批准号:32100456
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:黄艳
-
依托单位:
缺氧诱导的miR-210靶向BARD1调控细胞周期参与子宫内膜异位症的发展
-
批准号:81671435
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2016
-
负责人:张松英
-
依托单位:
BARD1与HUWE1在BRCA1依赖的乳腺癌发生发展中的作用及其机理研究
-
批准号:81602335
-
项目类别:青年科学基金项目
-
资助金额:17.0万元
-
批准年份:2016
-
负责人:王晓珍
-
依托单位:
BARD1过表达促进了乳腺癌他莫昔芬耐药的发生
-
批准号:81402505
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2014
-
负责人:朱英华
-
依托单位:
功能性遗传变异调控BARD1/BRCA1泛素化通路的机制及与儿童神经母细胞瘤的关联研究
-
批准号:31401067
-
项目类别:青年科学基金项目
-
资助金额:28.0万元
-
批准年份:2014
-
负责人:郭永丽
-
依托单位: